Allurion (ALUR) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Allurion Revenue Highlights


Latest Revenue (Y)

$32.11M

Latest Revenue (Q)

$3.38M

Main Geography (Y)

All Other Countries

Allurion Revenue by Period


Allurion Revenue by Year

DateRevenueChange
2024-12-31$32.11M-39.94%
2023-12-31$53.47M-16.73%
2022-12-31$64.21M67.91%
2021-12-31$38.24M100.00%
2020-12-31--

Allurion generated $32.11M in revenue during NA 2024, up -39.94% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Allurion Revenue by Quarter

DateRevenueChange
2025-06-30$3.38M-39.44%
2025-03-31$5.58M-0.20%
2024-12-31$5.59M4.17%
2024-09-30$5.37M-54.39%
2024-06-30$11.77M25.36%
2024-03-31$9.39M13.98%
2023-12-31$8.23M-54.75%
2023-09-30$18.20M40.43%
2023-06-30$12.96M-7.90%
2023-03-31$14.07M-26.65%
2022-12-31$19.18M19.42%
2022-09-30$16.06M-1.14%
2022-06-30$16.25M27.82%
2022-03-31$12.71M100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31--

Allurion generated $3.38M in revenue during Q2 2025, up -39.44% compared to the previous quarter, and up 36.00% compared to the same period a year ago.

Allurion Revenue Breakdown


Allurion Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
All Other Countries$24.04M
SPAIN$4.01M
FRANCE$2.49M

Allurion's latest annual revenue breakdown by geography, as of Dec 24: All Other Countries (78.72%), SPAIN (13.13%), and FRANCE (8.15%).

Quarterly Revenue by Country

CountryJun 25Mar 25Dec 24Sep 24Jun 24Mar 24
FRANCE$274.00K-$2.43M$1.87M$1.67M-
ITALY$436.00K$511.00K----
SPAIN$786.00K$749.00K-$3.00M$1.45M$1.11M
All Other Countries$1.88M$4.15M$6.89M$3.35M$8.45M$5.35M
EGYPT-$600.00K----
AUSTRALIA---$543.00K--

Allurion's latest quarterly revenue breakdown by geography, as of Jun 25: All Other Countries (55.73%), SPAIN (23.26%), ITALY (12.90%), and FRANCE (8.11%).

Allurion Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
IRIXIRIDEX$48.67M$13.57M
HCTIHealthcare Triangle$33.20M$3.70M
ALURAllurion$32.11M$3.38M
LFWDLifeward$25.66M$5.03M
CODXCo-Diagnostics$3.92M$50.28K
XAIRBeyond Air$1.16M$1.76M
ICUSeaStar Medical$135.00K$293.00K
NVNOenVVeno Medical--
ATHAAthira Pharma--
CLRBCellectar Biosciences--
SNSESensei Biotherapeutics--

ALUR Revenue FAQ


What is Allurion’s yearly revenue?

Allurion's yearly revenue for 2024 was $32.11M, representing a decrease of -39.94% compared to 2023. The company's yearly revenue for 2023 was $53.47M, representing a decrease of -16.73% compared to 2022. ALUR's yearly revenue for 2022 was $64.21M, representing an increase of 67.91% compared to 2021.

What is Allurion’s quarterly revenue?

Allurion's quarterly revenue for Q2 2025 was $3.38M, a -39.44% decrease from the previous quarter (Q1 2025), and a -71.28% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $5.58M, a -0.20% decrease from the previous quarter (Q4 2024), and a -40.55% decrease year-over-year (Q1 2024). ALUR's quarterly revenue for Q4 2024 was $5.59M, a 4.17% increase from the previous quarter (Q3 2024), and a -32.11% decrease year-over-year (Q4 2023).

What is Allurion’s revenue growth rate?

Allurion's revenue growth rate for the last 3 years (2022-2024) was -49.99%, and for the last 5 years (2020-2024) was 0%.